Skip to main content
Premium Trial:

Request an Annual Quote

UC Davis Cancer Center, Foundation Medicine to Collaborate on Data Sharing

NEW YORK (GenomeWeb) – The University of California Davis Comprehensive Cancer Center and the department of pathology and laboratory medicine today announced a data-sharing collaboration with Foundation Medicine. 

UC Davis will leverage molecular information from Foundation to drive targeted programs, research initiatives, and clinical trials to potentially improve patient outcomes. In return, the university will share outcomes data from its efforts to incorporate into Foundation's molecular information knowledgebase, FoundationCORE, to provide the cancer and pathology communities information that can be used to treat other patients, UC Davis said. 

FoundationCORE is a genomic knowledgebase of more than 35,000 genomic profiles. 

UC Davis said that the partners intend to develop a genomic tumor board to evaluate patient cases and enable oncologists at the UC Davis cancer center to determine the most appropriate treatments based on a patient's genomic profile. UC Davis and Foundation are also discussing grand round lectures, medical school courses focused on molecularly targeted treatments for cancer, and other continued medical educational opportunities, UC Davis said. 

Additionally, Ralph de Vere White, a professor of urology and director at the cancer center, will work with Foundation and payors to develop a protocol to streamline clinical trial enrollment and enable the coverage of patients for testing and treatment with therapies approved by the US Food and Drug Administration and molecularly driven drug trials.